Marker Therapeutics, Inc.MRKRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9852.6%
5Y CAGR+1342.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+9852.6%/yr
vs -44.3%/yr prior
5Y CAGR
+1342.7%/yr
Recent acceleration
Acceleration
+9896.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
624922.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.80T | +87609714.3% |
| 2024 | $13.47M | +29.3% |
| 2023 | $10.42M | -13.0% |
| 2022 | $11.97M | -56.9% |
| 2021 | $27.79M | +47.2% |
| 2020 | $18.88M | +47.9% |
| 2019 | $12.76M | -89.7% |
| 2018 | $124.00M | +2261.4% |
| 2017 | $5.25M | +38.2% |
| 2016 | $3.80M | - |